Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
DarioHealth ( (DRIO) ) has provided an announcement.
On February 25, 2025, DarioHealth Corp. appointed Lawrence Leisure to its Board of Directors, effective immediately. Leisure, with extensive experience in healthcare consulting and private equity, is expected to guide Dario’s expansion in payer and employer markets, enhancing its AI-driven chronic care platform. His appointment follows the resignation of Jon Kaplan from the Board on February 24, 2025.
More about DarioHealth
DarioHealth Corp. is a leading digital health company specializing in AI-driven solutions for managing chronic conditions. Their platform offers personalized interventions for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health, aiming to provide continuous and customized care to disrupt traditional healthcare approaches.
YTD Price Performance: -15.85%
Average Trading Volume: 726,195
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: $26.49M
For an in-depth examination of DRIO stock, go to TipRanks’ Stock Analysis page.